ALT (U/L) showed a significant (p ≤ .05) decrease in STD group (77.5 ± 1.75 U/L) and in the treatment groups G1 (76.32 ± 1.49 U/L), G2 (72.02 ± 0.87 U/L), and G3 (67.3 ± 1.41 U/L) compared to PC (88.87 ± 1.47 U/L). The gene discussed is GPT; the disease is sexually transmitted disease.